Skip to content

Implementation of an artificial intelligence module on the online imaging portal MYO-Share for guiding the diagnosis of muscle diseases

MYO-Guide: a machine learning approach to the analysis of MRI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN14323809
Enrollment
2000
Registered
2023-06-06
Start date
2021-09-01
Completion date
Unknown
Last updated
2023-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular diseases Musculoskeletal Diseases

Interventions

The Newcastle University research team will score muscle MRI images already obtained for diagnosis in clinics using the Lamminen-Mercuri scale (Diaz-Manera 2015). The numerical data from these scores

Sponsors

Newcastle University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This is a data archive study and no patients will be recruited into the study. This study will be using historical muscle MRI scans as well as limited patient data (i.e. age, sex, and genetic diagnosis of muscle disease)

Exclusion criteria

Exclusion criteria: This is a data archive study and no patients will be recruited into the study. This study will be using historical muscle MRI scans as well as limited patient data (i.e. age, sex, and genetic diagnosis of muscle disease)

Design outcomes

Primary

MeasureTime frame
1. To develop an artificial intelligence tool using machine learning that can guide the genetic diagnosis of muscle disorders based on the analysis of muscle MRIs. 2. To develop an artificial intelligence tool using a methodology called neural network, which will automatically identify and segment pelvic and leg muscles to quantify the amount of fat present in the skeletal muscles. 3. To collect many muscle MRIs of patients with different genetically confirmed muscles diseases. 4. To score fat replacement of all muscles of the pelvis and legs of the new cohort of patients included in the study. 5. To generate a new version of the MYO-Share platform containing MYO-Guide and the automatic segmentation tool. The MRI images of muscles from patients who have a neuromuscular disease will be included in this study. The purpose of this image data collection is twofold: 1) to inform the artificial intelligence tool used for diagnosis and 2) to inform the artificial intelligence tool used to automatically segment MRIs. For the diagnosis tool, the anonymised MRI images and patient data will be obtained either via an online platform (MYO-Share) uploaded by NHS sites and health care settings around the world or from data archives and Newcastle University. The automatic segmentation software will be able to identify and delineate each single muscle in the pelvis, thigh, and leg. To build the automatic segmentation algorithm, anonymised MRIs will be obtained from Newcastle University. We will use a neural network approach to identify the muscles on the MRI and quantify the amount of fat present in the muscles. On a first step, we will delineate manually all muscles of the lower limbs using an imaging delineation tool and assign a label of each muscle creating what is known as masks. On a second step, we will use all the masks generated to train a neural network that wil

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

Canada, Chile, Denmark, England, France, Italy, Korea, South, Spain, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026